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http:WHAT THIS PAPER ADDS
The current study is the ﬁrst large-scale analysis, focused on inter-observer variability in sizing fenestrated and/
or branched aortic stent-grafts. The agreements between core laboratory and each rater were all moderate to
perfect; however, there were some signiﬁcant discrepancies, which may affect clinical results. These discrep-
ancies should be taken into account in sizing fenestrated and/or branched stent-grafts.Background: Several studies have examined inter-observer variability in measurements for standard EVAR, but
little is known about measurements for complex aortic aneurysm.
Methods: Two independent observers reviewed all preoperative CT scans of 268 patients in a French trial of
fenestrated and/or branched aortic stent-grafts (f/b-EVAR). Those data were compared with those obtained (1)
by investigators (extent of aneurysm, target vessel stenosis, and aortic diameters), and (2) from manufacturers
(proximal landing zone, device diameter, and target vessel position). We assessed the reproducibility using kappa
statistics for qualitative data and both BlandeAltman plot and PassingeBablok regression analysis for
quantitative data.
Results: Reproducibility was moderate to almost perfect for all factors. However, a few critical discrepancies were
found, such as target vessel clock position (45 minutes) and location (5 mm), level of proximal landing zone,
and diameters of the endograft.
Conclusions: This is the ﬁrst large-scale analysis focused on inter-observer variability in sizing for f/b-EVAR. The
measurement data showed good agreement, but there were some critical discrepancies between observers that
may affect clinical results.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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branched endovascular aortic repair (f/b-EVAR), is a recent
development.1e3 Although commercially available stan-
dardized devices have been developed, at present custom-
made devices are used in the mainstream in this area.4e6
Whereas standardized devices are designed to be suitable
for a certain average anatomy, custom-made devices
require accurate preoperative sizing of stent-grafts for
technical success. The design of a custom-made device is
based on an individual CT scan provided by a surgeon.
Device planning requires experience in imaging and 3D
reconstruction using a workstation to make all the neces-
sary measurements. In the majority of cases, this sizing isrresponding author. H. Banno, Departments of Vascular Surgery,
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//dx.doi.org/10.1016/j.ejvs.2013.10.008performed by specialists in a centralized planning facility of
the manufacturer.
Inter-observer variability in various exams is well known.
Some authors have reported inter-observer variability in
measurements of abdominal aortic aneurysm (AAA).7,8
However, at present, little is known about any discrepancy
of sizing of complex aortic stent-grafts between different
specialists and between clinicians and manufacturers. This
study investigates the variability between experienced
endovascular surgeons and investigator or manufacture
measurements in measuring and sizing endovascular
aneurysm repair using fenestrated and/or branched stent-
grafts.
METHODS
WINDOWS study CT scans
WINDOWS Study is a multicenter, prospective single-arm
trial of f/b-EVAR for complex aortic aneurysms e abdom-
inal (juxta-, para-, and suprarenal AAA) or thor-
acoabdominal (TAAA) e in centers selected according to
46 H. Banno et al.their expertise in this technique and their compliance with
the recommendations of the French Health Authority (HAS:
Haute Autorité de Santé). All patients had preoperative CT
scans and patient inclusion was validated by both the in-
clusion criteria committee of WINDOWS study and the
planning center of manufacturer. Between September 2009
and October 2012, 268 patients were included in the trial
(the study is registered # NCT01168037 at clinicaltrials.gov
(http://www.clinicaltrials.gov/ct2/show/NCT01168037)).
In this study, all the preoperative CT scans were collected
and reviewed by the core laboratory. Planning center data
of the manufacturer were collected, as well as data pro-
vided by investigators. The quality of the retrieved scans
varied widely in terms of slice thickness (1 mm to 5 mm)
and scanning interval after contrast injection, and thus not
all scans were optimal for sizing fenestrated and/or
branched endograft.Image analysis
Two independent observers performed image analysis as
the core laboratory. A three-dimensional imaging worksta-
tion (TeraRecon Inc., Santa Rosa, CA, USA.) was used to
generate multiple three-dimensional reconstructions of
volumetric data sets from the preoperative CT scans. Both
observers were well-trained and experienced vascular sur-
geons. The third observer, an experienced interventional
radiologist, provided the ﬁnal decision as a core laboratory
in case of discrepancy in categorization between the two
observers. As for the quantitative data, mean values of the
two observers were determined as core laboratory data.
Extent of aneurysm was classiﬁed according to reporting
standards for thoracic endovascular aortic repair (TEVAR)
and ACC/AHA guidelines.9,10 As for paravisceral aneurysm,
juxtarenal aneurysms arise distal to the renal arteries but in
very close proximity to them; pararenal aneurysms involve
the origin of one or both renal arteries; suprarenal aneu-
rysms encompass the visceral aortic segment containing the
superior mesenteric and celiac arteries.
Eventual stenosis (>70%) of visceral branches (celiac axis
[CA], superior mesenteric artery [SMA], right renal artery
[RRA], left renal artery [LRA]) was identiﬁed. Stenosis
determination was made by measuring the ratio between
the diameter of the narrowest segment of the imaged ar-
tery (a) and the diameter of a normal segment of the artery
proximal to the stenosis or distal to poststenotic dilation (b)
(Percentage of stenosis ¼ (b  a)/b  100).
A semi-automated centerline was generated using the
above-mentioned workstation. The centerline was assessed
with multiplanar reconstruction views perpendicular to the
centerline of ﬂow, and then manually edited if necessary.
Aortic diameters at each level of visceral branches (CA,
SMA, RRA, and LRA), thoracic and infrarenal aortic diameter
were measured in perpendicular planes to the centerline.
Visceral artery orientation was measured relative to a line
extending anteriorly from the centerline of the aorta.
Clockwise deviation was assigned a positive value, and
counterclockwise deviation a negative value. The average ofangles estimated by two observers was deﬁned as the angle
of core laboratory. And then, all degrees were converted to
clock positions for analysis considering 0 as 12 o’clock
because some data about target vessel orientation obtained
from manufacturer were described only as clock positions.
For measuring longitudinal vessel separation, a stretch
view was used. The distance between the center of each
target vessel ostium and the low margin of CA ostium was
measured. In the case when information of CA could not be
obtained, the low margin of SMA ostium was substituted as
a reference point.
The proximal aorta was considered to be suitable as a
landing zone when the length of healthy aorta was
15 mm. Aneurysms were sub-divided into zones according
to where it was thought an adequate proximal seal could be
achieved in relation to the visceral arteries. Zone 0 was a
seal below the lowest preserved renal artery, Zone 1 is
between renal arteries at different levels, Zone 2 was above
the renal arteries but below the SMA, Zone 3 was above the
SMA but below the CA and Zone 4 was above the CA (Dr. K.
Ivancev, personal communication, June 2013).
The proximal device diameter was determined according
to the aortic diameter in the proximal seal zone and in
agreement with the instructions for use of the
manufacturer.
Comparing data
Data about extent of aneurysm, stenosis of visceral
branches, and aortic diameter, were obtained from each
center. They were estimated or measured by their own way
in daily practice. Orientation of visceral arteries, distance
from low margin of CA (or SMA), and proximal device
diameter were obtained from the manufacturer. The prox-
imal seal zone that the manufacturer proposed was ob-
tained from the planning sheet of the manufacturer. (A
circumferential seal was expected at the level of fenestra-
tion but scallop, which means that the proximal landing
zone was considered distal to the scallop if the device
incorporated a scallop.)
Data analysis
All statistical analyses were performed using SAS version 9.3
(SAS Institute, Cary, NC, USA) or R statistical software,
version 3.0.0 (A language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna,
Austria). Quantitative and qualitative variables were
analyzed separately by several methods. For quantitative
variables, agreement between the core laboratory and
raters was assessed by plotting the difference between each
reading and the reference with the limits of agreement
(two standard deviations around the mean difference) as
described by Bland and Altman.11 Quantitative variables
were also analyzed by PassingeBablok regression.12 For
qualitative variables, reproducibility was assessed using the
weighted kappa statistics (quadratic weighting was
employed). Applying generally accepted deﬁnitions, kappa
values 0 indicate no agreement, 0 to 0.2 slight agreement,
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0.6 to 0.8 substantial agreement, and 0.8 to 1.0 almost
perfect agreement.13
RESULTS
Extent of aneurysm
Core laboratory classiﬁed all 268 patients according to the
extent of aneurysm: 136 juxtarenal, 48 pararenal, 16 su-
prarenal, 26 type IV thoracoabdominal (TAAA), 24 type III
TAAA, 16 type II TAAA, and 2 type I TAAA. Inter-observer
reproducibility showed all almost perfect results (kappa
value ¼ 0.91 with investigator, 0.99 with Observer 1, and
0.82 with Observer 2). There were some discrepancies,
however, that might lead to a difference in proximal landing
zone (Fig. 1).
Visceral artery stenosis
Core laboratory indicated stenosis >70% in 11.9% (31/261)
of CA, 0% (0/261) of SMA, 3.4% (9/261) of RRA, and 3.9%
(10/256) of LRA. Inter-observer reproducibility showed
moderate to almost perfect results (CA: 0.56 with Investi-
gator, 0.88 with Observer 1, and 0.69 with Observer 2. SMA:
kappa value could not be calculated because of the absenceObse
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Figure 1. Comparison of extent of aneurysm between the core laborato
two, and black box indicates the different extent.of stenosis. RRA: 0.41, 0.79, and 0.65, respectively; LRA:
0.54, 1.00, and 1.00, respectively).Aortic diameter
Aortic diameter at various levels (thoracic, CA, SMA, the
lowest renal artery, and infrarenal) showed excellent
agreements between core laboratory and each rater by
PassingeBablok regression analysis. Slopes and intercepts
were 1.01, 1.09 (Investigator), 1.00, 0.00 (Observer 1), 1.00,
0.00 (Observer 2) at thoracic level, 0.92, 3.37 (Investigator),
1.00, 0.00 (Observer 1), 1.00, 0.00 (Observer 2) at CA level,
0.96, 1.92 (Investigator), 1.00, 0.00 (Observer 1), 1.00, 0.00
(Observer 2) at SMA level, 0.92, 3.27 (Investigator), 1.00,
0.00 (Observer 1), 1.00, 0.00 (Observer 2) at the lowest
renal artery level, and 0.98, 1.23 (Investigator), 1.00, 0.88
(Observer 1), 1.00, -0.50 (Observer 2) at infrarenal level,
respectively.Visceral artery orientation
As for CA clock position, agreements with core laboratory
were all almost perfect (kappa value: 0.80 (Manufacturer),
0.92 (Observer 1), and 0.94 (Observer 2)). Cases that had
discrepancy 45 minutes compared with core laboratoryrver2
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ry and each rater. Gray box indicates the same extent between the
48 H. Banno et al.were 2.3% (3/128) (Manufacturer), 0 (Observer 1), and
0 (Observer 2). As for SMA clock position, agreements with
core laboratory were all almost perfect (kappa value: 0.81
(Manufacturer), 0.94 (Observer 1), and 0.93 (Observer 2)).
The cases that had discrepancy 45 minutes compared
with core laboratory were 1.5% (3/199) (Manufacturer),
0 (Observer 1), and 0 (Observer 2). As for RRA clock posi-
tion, agreements with core laboratory were substantial to
almost perfect (kappa value: 0.64 (Manufacturer), 0.93
(Observer 1), and 0.92 (Observer 2)). The cases that had
discrepancy 45 minutes compared with core laboratory
were 3.6% (7/195) (Manufacturer), 1.0% (2/195) (Observer
1), and 1.5% (3/195) (Observer 2). As for LRA clock position,
agreements with core laboratory were all almost perfect
(kappa value: 0.84 (Manufacturer), 0.95 (Observer 1), and
0.95 (Observer 2). The cases that had discrepancy 45
minutes compared with core laboratory were 6.2% (12/193)10 15 20 25 30 35 40
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Figure 2. Comparison of visceral artery distance between the core labor
Superior mesenteric artery (SMA). Middle: Right renal artery (RRA). Lo(Manufacturer), 0.5% (1/193) (Observer 1), and 0.5% (1/
193) (Observer 2) (Fig. S1).Visceral artery distance
Both BlandeAltman plot and PassingeBablok regression
showed good reproducibility for distances between all
visceral artery and low margin of CA ostium. As for SMA,
slopes and intercepts were 0.86, 0.47 (Manufacturer), 1.01,
e2.36 (Observer 1), and 1.01, 1.96 (Observer 2). A differ-
ence 5 mm was noticed in 16.4% (21/128) (Manufac-
turer). As for RRA, slopes and intercepts were 0.95, e0.48
(Manufacturer), 0.97, e0.31 (Observer 1), and 1.05, e0.02
(Observer 2). The cases that had difference 5 mm
compared with core laboratory were 13.9% (27/194)
(Manufacturer). As for LRA, slopes and intercepts were 0.94,
e0.19 (Manufacturer), 0.95, 0.44 (Observer 1), and 1.06, e25 30 35 40
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compared with core laboratory were 13.0% (25/192)
(Manufacturer) ,(Fig. 2, Fig. S2).
Proximal landing zone
Proposed proximal landing zone compared with core labo-
ratory are shown in Fig. 3. Agreements were all almost
perfect (kappa value ¼ 0.82 with Manufacturer, 0.95 with
Observer 1, and 0.80 with Observer 2). There were some
discrepancies, however, as well as extent of aneurysm. And
there were more cases that were proposed more proximally
for PLZ by the core laboratory compared with the manu-
facturer in the ﬁrst half of this trial, whereas more cases
proposed more distally in the last half. These results did not
show any statistical difference.
Proximal device diameter
Proximal device diameters proposed by core laboratory and
raters or manufacturer are shown in Fig. 4. Each agreement
was good to almost perfect (kappa value ¼ 0.83 with
Manufacturer, 0.94 with Observer 1, and 0.93 with
Observer 2). The cases with discrepancy of 2 size in device
diameter were 23.5% (46/196) (Manufacturer), 4.1% (8/
196) (Observer 1), and 3.6% (7/196) (Observer 2) whenObserver1
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Figure 3. Comparison of proposed proximal landing zone (PLZ)
between the core laboratory and each rater. Gray box indicates the
same PLZ between the two, and black box indicates the different
PLZ.
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Figure 4. Comparison of proposed proximal device diameter be-
tween the core laboratory and each rater. Gray box indicates the
same diameter between the two, and black box indicates two
size discrepancy.compared with device diameter proposed by the core
laboratory.
DISCUSSION
This study is the ﬁrst large-scale report focused on inter-
observer variability of preoperative measurement and
sizing for f/b-EVAR by reviewing CT scans of the French
multicenter trial.
Several methods are available for preoperative sizing, but
centerline analysis is generally used for particularly complex
endovascular aortic surgery. Some authors emphasize the
usefulness and accuracy of centerline analysis, stating that (1)
it is associated with a decreased number of iliac limb exten-
sions, (2) distance calculations provide accurate length se-
lection of the stent-graft in themajority of cases.14,15 But, the
calculation of an aortic centerline of ﬂow is done in a
consistently semi-automatic manner. Although the worksta-
tion calculates the center of the aortic lumen in the targeted
area, operators have to assess whether the line runs proper
path, and modify it if necessary. The operator must draw the
Figure 5. Comparison of target vessel measurement using the centerline drawn automatically by 3D workstation (left) and the manually
modiﬁed centerline (right). In this case, discrepancies of target vessel orientations were little, but there were 5 mm difference in the RRA
distance and 11 mm difference in the LRA distance between the two.
50 H. Banno et al.centerline manually in case of insufﬁcient contrast
enhancement for detecting arterial ﬂow automatically. In the
case of an angulated aorta, the operator must adjust the
centerline according to the predicted path in which the main
body will run. These processes require judgment and care of
the operator, and can cause inter-observer variability (Fig. 5).
However, little is known about inter-observer variability on
measurements for complex aortic aneurysm which requires
visceral branch preservation.16,17
In this study, agreements between the core laboratory
and each rater showed good results in all terms. However,
there were some cases with critical discrepancies, if we
deﬁned 45 minutes as the threshold value of vessel orien-
tation, and 5 mm as vessel distance. Although we do not
think that those discrepancies affect the success rate of
target vessel revascularizations or patency rate of target
vessels directly, at least they might have led to technical
difﬁculty, with a subsequent increase of the duration of
intervention. In the WINDOWS study, multivariate analysis
showed that duration of intervention was a factor, whichaffected 30-day and in-hospital mortality (and morbidity)
after f/b-EVAR (under publication). As for the proximal
landing zone (PLZ), some cases proposed a more proximal
part of the aorta for PLZ, but others proposed more distal
by the core laboratory compared with the manufacturer.
This is a signiﬁcant issue. The rate of type I EL can be
lowered by implanting an endograft with longer landing
zone. Conversely, occurrence of spinal cord ischemia can be
reduced if the endograft is implanted with shorter length. In
the WINDOWS trial, the incidence of spinal cord ischemia
was relatively high (4.1%) (under publication), and this is
one of the most important issues we face to improve the
clinical result. Interestingly as the manufacturer experi-
enced more cases of f/b-EVAR, they might have planned the
device implantation more proximally to ensure the exclu-
sion of aneurysm. We might be able to treat some cases
with shorter devices and reduce morbidities. Intraoperative
data and long-term results are awaited to investigate the
correlation between the discrepancy in the image analysis
and clinical results.
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Thequality of the retrieved scans variedwidely in termsof slice
thickness (1 mm to 5mm) and scanning interval after contrast
injection, and, thus not all scans were optimal for sizing
fenestrated and/or branched endografts. This variability of
quality may inﬂuence accuracy of measurement. We have
studied scans with slice thicknesses of 1e5 mm and it is likely
that poor scan quality may account for some disagreement in
terms of the setting of the landmarks, as the three-
dimensional software interpolates in between the slices.
We could not obtain information about the exact way to
create the centerline, and of measurement or sizing by
manufacturer. Although using the same workstation, there
may be some differences between the core laboratory and
manufacturer, which could lead to discrepancies.
In this study, a limited amount of data was analyzed and
other measurements, such as treatment length, the level of
distal landing zone, target vessel diameter, and landing
length, were not compared between each rater. Those data
are also important factors and should be estimated in a
subsequent study.
We obtained manufacturer sizing from their planning
sheet, but there were some cases in which we could not
obtain these, and, in addition, some of the acquired sheets
did not include all the contents. Thus, in those cases, we
substituted data from the device request form as the data
of sizing. As the data of branched device request forms may
be different from original sizing, those data were excluded
from analysis in this study.
We used measurements and assessment of the core
laboratory as a reference. Although the third observer
provided the ﬁnal decision as a core laboratory in case of
discrepancy in categorization between two observers, as for
quantitative values, the mean of two observers was deﬁned
as the data of core laboratory. Multi-observer analysis is
recommended for proper preoperative planning.
CONCLUSION
This is the ﬁrst large-scale analysis focused on inter-
observer variability of sizing for f/b-EVAR. The measure-
ment data showed good agreement, but there were some
critical discrepancies between observers that may affect
clinical results. These discrepancies should be taken into
account in sizing fenestrated and/or branched stent-grafts.
Intraoperative data and long-term results of those pa-
tients should be investigated to assess the role of proper
planning and the results of f/b-EVAR.CONFLICT OF INTEREST
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